Table 1.
Description of the study population between colorectal cancer patients with osteoglycin low and high expression
| Variables, N (%) | OGN | P value | |
|---|---|---|---|
| Low(N = 163) | High(N = 109) | ||
| Gender | |||
| Male | 101(62) | 62(56.9) | 0.40 |
| Female | 62(38) | 47(43.1) | |
| Age, years | 56.9 ± 10.7 | 57.3 ± 11.6 | 0.79 |
| TNM stage | 0.43 | ||
| I | 14(8.6) | 7(6.4) | |
| II | 49(30.1) | 32(29.4) | |
| III | 73(44.8) | 58(53.2) | |
| IV | 27(16.6) | 12(11.0) | |
| N stage | 0.16 | ||
| N0 | 74(45.4) | 46(42.2) | |
| N1 | 53(32.5) | 28(25.7) | |
| N2 | 36(22.1) | 35(32.1) | |
| M stage | 0.43 | ||
| M0 | 136(83.4) | 97(89.0) | |
| M1 | 27(16.6) | 12(11.0) | |
| Grade | 0.55 | ||
| Well/ moderate | 118(72.4) | 85(78.0) | |
| poor | 34(20.9) | 19(17.4) | |
| T stage | 0.74 | ||
| T2 | 27(16.6) | 16(14.7) | |
| T3 | 30(18.4) | 24(22.0) | |
| T4 | 106(65.0) | 69(63.3) | |
| Histological type | 0.28 | ||
| Adenocarcinoma | 152(93.3) | 105(96.3) | |
| Mucinous | 11(6.7) | 4(3.7) | |
| Lymph node examined | 0.17 | ||
| Median | 15 ± 7 | 16 ± 6 | |
| Perineural invasion | 0.26 | ||
| Negative | 133(82.1) | 95(87.2) | |
| Positive | 29(17.9) | 14(12.8) | |
| Vascular invasion | 0.25 | ||
| Negative | 108(66.3) | 75(68.8) | |
| Positive | 51(31.3) | 34(31.2) | |
| Adjuvant Chemotherapy | 0.37 | ||
| No | 30(18.4) | 18(16.5) | |
| Yes | 108(66.3) | 80(73.4) | |
| MS status/MMR status | 0.06 | ||
| MSS/MMR-proficient | 111(68.1) | 62(56.9) | |
| MSI/MMR-deficient | 52(31.9) | 47(43.1) | |
MMR indicates mismatch repair, MS microsatellite, MSS microsatellite stability, MSI microsatellite instability